Cargando…

Evaluation of Formosa score and diagnostic sensitivity and specificity of four Asian risk scores for predicting intravenous immunoglobulin resistance in Kawasaki disease: a bivariate meta-analysis

BACKGROUND: In 2016, Lin et al. developed a prediction score of non-responsiveness to intravenous immunoglobulin (IVIG) in patients with Kawasaki disease (KD) (Lin et al., 2016). Various studies have attempted to validate the Formosa score, but inconsistent results have given us new opportunities an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Wan-Ni, Huang, Po-Yu, Kuo, Ho-Chang, Huang, Ying-Hsien, Chang, Ling-Sai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291052/ https://www.ncbi.nlm.nih.gov/pubmed/37378410 http://dx.doi.org/10.3389/fcvm.2023.1164530

Ejemplares similares

Establishment and Validation of a Multivariate Predictive Scoring Model for Intravenous Immunoglobulin-Resistant Kawasaki Disease: A Study of Children From Two Centers in China
por: Li, Changjian, et al.
Publicado: (2022)

Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin
por: Huang, Ying-Hua, et al.
Publicado: (2021)

Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Chen, Chih-Jen, et al.
Publicado: (2012)

A novel model for predicting intravenous immunoglobulin-resistance in Kawasaki disease: a large cohort study
por: Wang, Shuhui, et al.
Publicado: (2023)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
por: Yu, Hun-Ju, et al.
Publicado: (2021)

Comparison of the Laboratory Data Between Kawasaki Disease and Enterovirus After Intravenous Immunoglobulin Treatment
por: Lin, Li-Yan, et al.
Publicado: (2012)

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
por: Kuo, Ho-Chang, et al.
Publicado: (2018)

C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Tsai, Chih-Min, et al.
Publicado: (2020)

Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2017)

Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease
por: Ou-Yang, Mei-Chen, et al.
Publicado: (2013)

Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome
por: Rigante, Donato, et al.
Publicado: (2016)

Novel Predictive Scoring System for Intravenous Immunoglobulin Resistance Helps Timely Intervention in Kawasaki Disease: The Chinese Experience
por: Wang, Yan, et al.
Publicado: (2023)

Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease
por: Liu, Xiaoliang, et al.
Publicado: (2021)

A simple scoring model based on machine learning predicts intravenous immunoglobulin resistance in Kawasaki disease
por: Sunaga, Yuto, et al.
Publicado: (2023)

Utility of PREDICT-HF score in high-risk Asian heart failure patients receiving sacubitril/valsartan
por: Hsu, Chien-Yi, et al.
Publicado: (2022)

Kawasaki Disease and Allergic Diseases
por: Huang, Po-Yu, et al.
Publicado: (2021)

A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old
por: Wu, Shu, et al.
Publicado: (2019)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease
por: Piram, Maryam, et al.
Publicado: (2020)

Combination of Hemoglobin-for-Age Z-Score and Plasma Hepcidin Identified as a Novel Predictor for Kawasaki Disease
por: Yang, Ya-Ling, et al.
Publicado: (2022)

Correction to: A simple scoring model based on machine learning predicts intravenous immunoglobulin resistance in Kawasaki disease
por: Sunaga, Yuto, et al.
Publicado: (2023)

Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022)

Importance of predicting non-response to intravenous immunoglobulin therapy in non-Asian patients with Kawasaki disease
por: Koné-Paut, Isabelle, et al.
Publicado: (2022)

Significantly Lower Immunoglobulin M Levels 6 Months After Disease Onset in Patients With Kawasaki Disease With Coronary Artery Lesions
por: Chang, Ling‐Sai, et al.
Publicado: (2021)

Randomized trial of different initial intravenous immunoglobulin regimens in Kawasaki disease
por: He, Lan, et al.
Publicado: (2021)

Echocardiography and laboratory outcomes of COVID-19 in children with a history of Kawasaki disease: a preliminary observation
por: Guo, Mindy Ming-Huey, et al.
Publicado: (2023)

Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
por: Ko, Tai-Ming, et al.
Publicado: (2018)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
por: Song, Min Seob
Publicado: (2019)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
por: Nadig, Pallavi L., et al.
Publicado: (2023)

Comparative effectiveness of two intravenous immunoglobulin products in children with Kawasaki disease, a nationwide cohort study
por: Kuo, Ni-Chun, et al.
Publicado: (2023)

Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease
por: Chang, Ling-Sai, et al.
Publicado: (2020)

A novel score system of blood tests for differentiating Kawasaki disease from febrile children
por: Tsai, Chih-Min, et al.
Publicado: (2021)

FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2015)

The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease
por: Chang, Ling-Sai, et al.
Publicado: (2016)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

Smoothing of the bivariate LOD score for non-normal quantitative traits
por: Buil, Alfonso, et al.
Publicado: (2005)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Expression of Eosinophilic Subtype Markers in Patients with Kawasaki Disease
por: Chang, Ling-Sai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r17f9s4tsuvan7v93jnso761qi